| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Abstracts author index
|
|
|
|
3 |
1 |
p. S139-S151
|
artikel
|
| 2 |
Abstracts of the 4th Congress of ECCO – the European Crohn's and Colitis Organisation Hamburg, Germany, February 5–7, 2009
|
|
|
|
3 |
1 |
p. S1
|
artikel
|
| 3 |
An economic evaluation comparing once daily with twice daily mesalazine for maintaining remission based on results from a randomised controlled clinical trial
|
Connolly, Mark P.
|
|
|
3 |
1 |
p. 32-37
|
artikel
|
| 4 |
8 - Azathioprine/biological therapy does prevent surgery but not reoperation in smokers with Crohn's disease
|
Szamosi, T.
|
|
|
3 |
1 |
p. S6
|
artikel
|
| 5 |
3 - Azathioprine modulates human monocyte function via the PAK-2 signaling pathway
|
Zhou, L.
|
|
|
3 |
1 |
p. S4
|
artikel
|
| 6 |
14 - Clinical course and cost of care in ulcerative colitis: Markov chain analysis of a European prospective population-based cohort
|
Odes, S.
|
|
|
3 |
1 |
p. S9
|
artikel
|
| 7 |
1 - Colonic mucosal expression of barrier genes in patients with inflammatory bowel disease before and after first infliximab treatment
|
Arijs, I.
|
|
|
3 |
1 |
p. S3
|
artikel
|
| 8 |
European Crohn's and Colitis OrganisationInstructions for Authors
|
|
|
|
3 |
1 |
p. i-ii
|
artikel
|
| 9 |
First endoscopic appearance of ulcerative colitis
|
De Vos tot Nederveen Cappel, W.H.
|
|
|
3 |
1 |
p. 42-43
|
artikel
|
| 10 |
9 - Geographic distribution of inflammatory bowel disease (IBD) in France is influenced by sunlight exposure
|
Nerich, V.
|
|
|
3 |
1 |
p. S6-S7
|
artikel
|
| 11 |
12 - Immunosuppressive (IS) therapy impacts the results of Quantiferon® and tuberculin skin test in routine screening for latent tuberculosis (LTB) in patients with inflammatory bowel diseases (IBD)
|
Papay, P.
|
|
|
3 |
1 |
p. S8
|
artikel
|
| 12 |
Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease
|
Bossuyt, Peter
|
|
|
3 |
1 |
p. 4-7
|
artikel
|
| 13 |
Infliximab and refractory ulcerative colitis
|
Caprilli, R.
|
|
|
3 |
1 |
p. 44
|
artikel
|
| 14 |
11 - Lack of usefulness of systematic determination of azathioprine (AZA) metabolites during follow-up of inflammatory bowel disease (IBD) patients under thiopurinic therapy: final results of the Metaza Study
|
Gonzalez-Lama, Y.
|
|
|
3 |
1 |
p. S7-S8
|
artikel
|
| 15 |
15 - Laparoscopic-assisted versus open ileocolic resection for Crohn's disease: long term results of a prospective randomized trial
|
Eshuis, E.J.
|
|
|
3 |
1 |
p. S9-S10
|
artikel
|
| 16 |
5 - Neutrophil accumulation and bacterial clearance are delayed in patients with Crohn's disease
|
Hayee, B.
|
|
|
3 |
1 |
p. S4-S5
|
artikel
|
| 17 |
Non-toxic megacolon due to transverse and sigmoid colon volvulus in a patient with ulcerative colitis
|
Katsanos, Konstantinos
|
|
|
3 |
1 |
p. 38-41
|
artikel
|
| 18 |
P272 - Abnormal TLR4-mediated interferon response in ulcerative colitis
|
Rahman, F.Z.
|
|
|
3 |
1 |
p. S118
|
artikel
|
| 19 |
P290 - Absence of placental growth factor aggravates DSS-induced acute colonic injury
|
Hindryckx, P.
|
|
|
3 |
1 |
p. S124-S125
|
artikel
|
| 20 |
P032 - A colorectal mosaic pattern might be an endoscopic feature of collagenous colitis
|
Cimmino, D.
|
|
|
3 |
1 |
p. S23
|
artikel
|
| 21 |
P145 - Adalimumab in a clinical practice – experience with human anti TNF-α therapy in tertiary clinical center
|
Bortlik, M.
|
|
|
3 |
1 |
p. S68
|
artikel
|
| 22 |
P184 - Adalimumab in the treatment of active luminal and perianal Crohn's disease: a single center experience in 100 patients
|
Rizzello, F.
|
|
|
3 |
1 |
p. S83
|
artikel
|
| 23 |
P148 - Adalimumab maintains long-term remission in patients with moderately to severely active Crohn's disease through 3 years of therapy
|
Panaccione, R.
|
|
|
3 |
1 |
p. S69-S70
|
artikel
|
| 24 |
P118 - Adalimumab's effect on extraintestinal manifestations of Crohn's disease: results of the CARE trial
|
Louis, E.
|
|
|
3 |
1 |
p. S57-S58
|
artikel
|
| 25 |
P008 - Adalimumab sustains quality-of-life improvements in patients with Crohn's disease: 3-year data from CHARM
|
Loftus Jr., E.V.
|
|
|
3 |
1 |
p. S14
|
artikel
|
| 26 |
P038 - Adalimumab sustains remission and quality-of-life improvements in anti-TNF-naive patients with Crohn's disease: 3-year data from CHARM
|
Loftus Jr., E.V.
|
|
|
3 |
1 |
p. S26
|
artikel
|
| 27 |
P140 - Adherence to scheduled infliximab treatment in inflammatory bowel disease
|
Theodoropoulos, I.
|
|
|
3 |
1 |
p. S66-S67
|
artikel
|
| 28 |
P133 - Adherence to therapy and use of complementary and alternative medicine in patients with inflammatory bowel diseases
|
Lakatos, P.L.
|
|
|
3 |
1 |
p. S63-S64
|
artikel
|
| 29 |
P322 - A first experimental approach to the effect of adalimumab treatment on the microbial composition of the intestinal mucosa in Crohn's disease patients
|
Mas-de-Xaxars, T.
|
|
|
3 |
1 |
p. S137
|
artikel
|
| 30 |
P309 - Altered imprinting of lymphocyte homing by colonic dendritic cells in human ulcerative colitis
|
Ng, S.C.
|
|
|
3 |
1 |
p. S132
|
artikel
|
| 31 |
P181 - 5-Aminosalicylic acid dependency in Crohn's disease
|
Duricova, D.
|
|
|
3 |
1 |
p. S82
|
artikel
|
| 32 |
P235 - Analysis of non-synonymous single nucleotide polymorphism at diamine oxidase gene (refSNP Id: Rs1049793) in patients with Crohn's disease
|
López-Palacios, N.
|
|
|
3 |
1 |
p. S103-S104
|
artikel
|
| 33 |
P259 - An FcRL3 gene promoter variant is associated with peripheral arthritis in Crohn's disease
|
Mendoza, J.L.
|
|
|
3 |
1 |
p. S113
|
artikel
|
| 34 |
P044 - Anorectal function and rectal sensitivity in inflammatory bowel disease
|
Petryszyn, P.W.
|
|
|
3 |
1 |
p. S28
|
artikel
|
| 35 |
P198 - Anti-infliximab antibodies in routine clinical practice – is it worth to assess them?
|
Lukas, M.
|
|
|
3 |
1 |
p. S88
|
artikel
|
| 36 |
P320 - Antimutagenic activity of the probiotic E. coli strain Nissle 1917
|
Sonnenborn, U.
|
|
|
3 |
1 |
p. S136
|
artikel
|
| 37 |
P016 - Antinuclear antibodies: a marker associated with steroid dependence in patients with ulcerative colitis
|
Yamamoto-Furusho, J.K.
|
|
|
3 |
1 |
p. S17
|
artikel
|
| 38 |
P160 - Anti-TNF therapy prior to intestinal resection for symptomatic stenotic small bowel Crohn's disease
|
Treton, X.
|
|
|
3 |
1 |
p. S74
|
artikel
|
| 39 |
P255 - Anxiety and depression symptoms in Crohn's disease patients in remission
|
Iglesias, M.
|
|
|
3 |
1 |
p. S111-S112
|
artikel
|
| 40 |
P200 - A phase I, age and gender stratified, open-label, parallel-group, single-dose study assessing pharmacokinetics (PK) of a single 4.8 g oral dose of MMX™ the mesalazine in healthy volunteers
|
Pierce, D.
|
|
|
3 |
1 |
p. S89
|
artikel
|
| 41 |
P178 - A pilot study of elemental diet for chronic pouchitis
|
McLaughlin, S.D.
|
|
|
3 |
1 |
p. S81
|
artikel
|
| 42 |
P209 - A randomised controlled trial with Probio-Tec AB-25 for maintenance of remission in ulcerative colitis
|
Wildt, S.
|
|
|
3 |
1 |
p. S93
|
artikel
|
| 43 |
P282 - ASCA IgA and IgG titers predict Crohn's disease phenotype in Romanian patients
|
Iacob, R.
|
|
|
3 |
1 |
p. S121-S122
|
artikel
|
| 44 |
P194 - Assessment of self-efficacy during transition in adolescents with inflammatory bowel disease
|
Zijlstra, M.
|
|
|
3 |
1 |
p. S87
|
artikel
|
| 45 |
P225 - Association between NOD2, ATG16L1 And IL23R gene polymorphisms and childhood-onset of Crohn's disease: results from a case control study among Greek cases
|
Gazouli, M.
|
|
|
3 |
1 |
p. S99
|
artikel
|
| 46 |
P240 - Association between non-synonymous variant in the MST1 gene and IBD in Italian population
|
Latiano, A.
|
|
|
3 |
1 |
p. S106
|
artikel
|
| 47 |
P022 - Attenuated response to purified protein derivative test in patients with inflammatory bowel disease
|
Kedrah Sr., A.E.
|
|
|
3 |
1 |
p. S20
|
artikel
|
| 48 |
P035 - Attenuated response to purified protein derivative test in patients with inflammatory bowel disease
|
Kedrah Sr., A.E.
|
|
|
3 |
1 |
p. S24-S25
|
artikel
|
| 49 |
10 - Patterns and predictors of dosage increase in patients treated with adalimumab for Crohn's disease in the United States
|
Loftus Jr., E.V.
|
|
|
3 |
1 |
p. S7
|
artikel
|
| 50 |
P012 - Atypical perinuclear anti-neutrophil cytoplasmic antibodies (x-ANCA) are associated with disease extent and arthralgia in patients with ulcerative colitis
|
Yamamoto-Furusho, J.K.
|
|
|
3 |
1 |
p. S16
|
artikel
|
| 51 |
P050 - Atypical pyoderma gangrenosum in the neck mimicking acute neurological illness in IBD patient; case report
|
Premuzic, M.
|
|
|
3 |
1 |
p. S30-S31
|
artikel
|
| 52 |
P116 - Autologous haematopoietic stem cell transplantation for refractory Crohn's disease: updating the Milan experience without CD34+ cell selection
|
Cassinotti, A.
|
|
|
3 |
1 |
p. S56-S57
|
artikel
|
| 53 |
P090 - Autologous mesenchymal stem cell therapy in patients with refractory Crohn's disease
|
Duijvestein, M.
|
|
|
3 |
1 |
p. S46-S47
|
artikel
|
| 54 |
P056 - Autologous Stem Cell Transplantation For Crohn's disease (ASTIC) trial: early report of toxicity and efficacy
|
Hawkey, C.J.
|
|
|
3 |
1 |
p. S33
|
artikel
|
| 55 |
P250 - Autophagy 16-like 1 on chromosome 2q37.1 is associated with inflammatory bowel disease in children
|
Jurik, A.
|
|
|
3 |
1 |
p. S110
|
artikel
|
| 56 |
P154 - Azathioprine and 6-mercaptopurine for the prevention of postoperative recurrence in Crohn's disease: a meta-analysis of controlled trials with individual patient data
|
Peyrin-Biroulet, L.
|
|
|
3 |
1 |
p. S72
|
artikel
|
| 57 |
P101 - Azathioprine-associated lymphopenia in IBD – are our patients in danger? A prospective multi-centre study
|
Al-Rifai, A.
|
|
|
3 |
1 |
p. S51
|
artikel
|
| 58 |
P179 - Azathioprine use in patients with inflammatory bowel disease. How frequently do we encounter adverse events? A general hospital experience
|
Viazis, N.
|
|
|
3 |
1 |
p. S81
|
artikel
|
| 59 |
P319 - Biofilm formation of adherent-invasive Escherichia coli (AIEC): a novel phenotypic trait that could be related to AIEC pathogenesis
|
Martinez-Medina, M.
|
|
|
3 |
1 |
p. S136
|
artikel
|
| 60 |
P001 - Bowel sonography in predicting post-operative course of Crohn's disease
|
Castiglione, F.
|
|
|
3 |
1 |
p. S11
|
artikel
|
| 61 |
P288 - Breast cancer resistance protein (BCRP/ABCG2) expression is reduced during active colitis and translocated in IBD-related neoplasia
|
Koelewijn, C.L.
|
|
|
3 |
1 |
p. S124
|
artikel
|
| 62 |
P026 - Capsule endoscopy in indeterminate colitis/inflammatory bowel disease type unclassified — a single-center experience
|
Lopes, S.
|
|
|
3 |
1 |
p. S21
|
artikel
|
| 63 |
P072 - Capsule endoscopy in patients with suspected small bowel Crohn's disease: which findings should be considered diagnostic?
|
Viazis, N.
|
|
|
3 |
1 |
p. S39
|
artikel
|
| 64 |
P052 - Capsule endoscopy in suspected Crohn's disease — our initial experience
|
Sadio, A.
|
|
|
3 |
1 |
p. S31
|
artikel
|
| 65 |
P123 - Cardiac troponins in patients treated with biological therapy for inflammatory bowel disease
|
Taylor, K.
|
|
|
3 |
1 |
p. S59
|
artikel
|
| 66 |
P268 - Changes in expression profile of matrix metalloproteinases and tissue inhibitors of metalloproteinases in Crohn's disease after immunosuppressive treatment correlate with histological score and calprotectin values
|
Mäkitalo, L.
|
|
|
3 |
1 |
p. S116-S117
|
artikel
|
| 67 |
P252 - Characteristics of patients prospectively recruited in the Hungarian Pediatric IBD Registry (HUPIR)
|
Veres, G.
|
|
|
3 |
1 |
p. S110-S111
|
artikel
|
| 68 |
P313 - Circulating dendritic cells as a novel marker of disease activity in inflammatory bowel disease?
|
Radwan, P.
|
|
|
3 |
1 |
p. S133
|
artikel
|
| 69 |
P063 - Clinical course and cost of healthcare in Crohn's disease: Markov chain analysis of a European prospectively recruited population-based cohort
|
Odes, S.
|
|
|
3 |
1 |
p. S35-S36
|
artikel
|
| 70 |
P141 - Clinical effectiveness of granulocyte and monocyte apheresis (GMA) with the Adacolumn® device in ulcerative colitis – a meta-analysis
|
Habermalz, B.
|
|
|
3 |
1 |
p. S67
|
artikel
|
| 71 |
P132 - Clinical experience with adalimumab in a multicenter Swiss cohort of patients with Crohn's disease
|
Nichita, C.M.
|
|
|
3 |
1 |
p. S63
|
artikel
|
| 72 |
P277 - Clinical features of ulcerative colitis in pANCA-positive patients in Russian Federation
|
Kharitonov, A.G.
|
|
|
3 |
1 |
p. S120
|
artikel
|
| 73 |
P251 - Clinical parameters available in early Crohn's disease patients predict a progressive disease course and the subsequent need for immunosuppressive therapy
|
Wenger, S.
|
|
|
3 |
1 |
p. S110
|
artikel
|
| 74 |
P164 - Clinical pharmacology of vedolizumab (MLN0002) in patients with active ulcerative colitis
|
Scholz, C.
|
|
|
3 |
1 |
p. S75-S76
|
artikel
|
| 75 |
P321 - Clostridium difficile and extended spectrum beta-lactamase resistant (ESBL) bacteria in pouchitis patients
|
McLaughlin, S.D.
|
|
|
3 |
1 |
p. S136-S137
|
artikel
|
| 76 |
P170 - Complex perianal fistulas in Crohn's disease: infliximab, surgery or combined approach
|
Selvaggi, F.
|
|
|
3 |
1 |
p. S78
|
artikel
|
| 77 |
P107 - Complications and clinical outcome in chronic pouchitis patients treated with long-term antibiotic therapy
|
McLaughlin, S.D.
|
|
|
3 |
1 |
p. S53
|
artikel
|
| 78 |
P147 - Concomitant opportunistic systemic infections in a patient receiving infliximab and azathioprine for fistulizing Crohn's disease
|
Ministro, P.
|
|
|
3 |
1 |
p. S69
|
artikel
|
| 79 |
P213 - Concurrence of inflammatory bowel disease and multiple sclerosis in general population: frequency, phenotypes and clinical course
|
Buzaglo, G.
|
|
|
3 |
1 |
p. S94-S95
|
artikel
|
| 80 |
P294 - Control of interleukin-17 production in inflammatory bowel disease
|
Rovedatti, L.
|
|
|
3 |
1 |
p. S126
|
artikel
|
| 81 |
P228 - Coping with Crohn's disease according to gender
|
Iade, B.M.
|
|
|
3 |
1 |
p. S100-S101
|
artikel
|
| 82 |
P300 - Correlation of age and serum dipeptidyl peptidase IV (DPP IV/CD26) activity in patients with inflammatory bowel diseases
|
Varljen, J.
|
|
|
3 |
1 |
p. S129
|
artikel
|
| 83 |
P262 - Crohn's disease in the elderly: a comparison with young adults
|
Ouakaa-Kchaou, A.
|
|
|
3 |
1 |
p. S114
|
artikel
|
| 84 |
P223 - Crohn's disease is associated with low serum bilirubin levels
|
Lenicek, M.
|
|
|
3 |
1 |
p. S98-S99
|
artikel
|
| 85 |
P093 - Cyclophosphamide therapy for inflammatory bowel disease
|
Nagy, A.
|
|
|
3 |
1 |
p. S47-S48
|
artikel
|
| 86 |
P075 - Detection of K-ras and p53 gene mutations and hypermethylation of P16 in colonic lavage of patients with chronic inflammatory bowel diseases
|
Breitrueck, A.
|
|
|
3 |
1 |
p. S40
|
artikel
|
| 87 |
P019 - Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease
|
Petruzziello, C.
|
|
|
3 |
1 |
p. S18-S19
|
artikel
|
| 88 |
P171 - Differences in the health-related quality of life, affective status and personality in IBS and IBD patients
|
Tkalčić, M.
|
|
|
3 |
1 |
p. S78
|
artikel
|
| 89 |
P036 - Different character of oral mucosa changes in IBD
|
Paradowska, A.M.
|
|
|
3 |
1 |
p. S25
|
artikel
|
| 90 |
P248 - Differential effects of TNFα blockers on gene expression in LPS-stimulated monocytes
|
Fossati, G.
|
|
|
3 |
1 |
p. S109
|
artikel
|
| 91 |
P013 - Different segmental transit times through the small bowel may affect diagnostic efficacy of wireless capsule endoscopy
|
Pallotta, N.
|
|
|
3 |
1 |
p. S16
|
artikel
|
| 92 |
P192 - Disease duration does not affect outcome following infliximab therapy in children with Crohn's disease
|
Hyams, J.
|
|
|
3 |
1 |
p. S86
|
artikel
|
| 93 |
P202 - Diverting loop ileostomy after restorative proctocolectomy for ulcerative and indeterminate colitis: predictors of outcome and quality of life
|
Scarpa, M.
|
|
|
3 |
1 |
p. S90
|
artikel
|
| 94 |
P011 - Do inflammatory bowel disease (IBD) responders differ from non-responders to a postal questionnaire? Implications for generalizability
|
Bertram, S.
|
|
|
3 |
1 |
p. S15-S16
|
artikel
|
| 95 |
P152 - Double balloon enteroscopy: advancing the management of Crohn's disease small bowel strictures
|
Despott, E.J.
|
|
|
3 |
1 |
p. S71
|
artikel
|
| 96 |
P168 - Effects of anti-TNF-α treatments on each single variable of the Crohn's Disease Activity Index (CDAI): a prospective longitudinal study
|
Zorzi, F.
|
|
|
3 |
1 |
p. S77
|
artikel
|
| 97 |
P191 - Efficacy and safety in the use of infliximab in ulcerative colitis: analysis of a large single center cohort
|
Jürgens, M.
|
|
|
3 |
1 |
p. S85-S86
|
artikel
|
| 98 |
P136 - Efficacy and safety of adalimumab in children with active Crohn's disease: a prospective, open-label, single-centre trial
|
Civitelli, F.
|
|
|
3 |
1 |
p. S65
|
artikel
|
| 99 |
P177 - Efficacy and safety of infliximab in patients with ulcerative colitis intolerant or resistant to conventional treatment
|
Evesque, L.
|
|
|
3 |
1 |
p. S80-S81
|
artikel
|
| 100 |
P092 - Efficacy and safety of methotrexate therapy in inflammatory bowel disease. The Madrid experience
|
Gonzalez-Lama, Y.
|
|
|
3 |
1 |
p. S47
|
artikel
|
| 101 |
P124 - Efficacy and toxicity of tacrolimus in steroid resistant ulcerative colitis cannot be predicted by genetic polymorphisms of the CYP3 A4, CYP3 A5, ABCB1 and NR1I2 genes
|
Herrlinger, K.R.
|
|
|
3 |
1 |
p. S60
|
artikel
|
| 102 |
P211 - Efficacy of adalimumab in paediatric Crohn's disease patients naive to other anti-TNF treatments
|
Martín de Carpi, J.
|
|
|
3 |
1 |
p. S94
|
artikel
|
| 103 |
P173 - Efficacy of adalimumab in patients with Crohn's disease and failure to therapy with infliximab
|
Cordero Ruiz, P.
|
|
|
3 |
1 |
p. S79
|
artikel
|
| 104 |
P119 - Efficacy of azathioprine and mercaptopurine in ulcerative colitis. Systematic review and meta-analysis
|
Gisbert, J.P.
|
|
|
3 |
1 |
p. S58
|
artikel
|
| 105 |
P155 - Efficacy of enemas containing combination of mesalazine and methyl-prednisolone in active distal refractory ulcerative colitis
|
Gionchetti, P.
|
|
|
3 |
1 |
p. S72
|
artikel
|
| 106 |
P135 - Efficacy of infliximab in active refractory ulcerative colitis
|
Gionchetti, P.
|
|
|
3 |
1 |
p. S64
|
artikel
|
| 107 |
P156 - Emotional and behavioural problems and competence among adolescents with inflammatory bowel disease and their peers
|
Väistö, T.L.A.
|
|
|
3 |
1 |
p. S72-S73
|
artikel
|
| 108 |
P199 - Enrollment in IBD clinical research: the patient's point of view
|
Martinato, M.
|
|
|
3 |
1 |
p. S89
|
artikel
|
| 109 |
P128 - Enteral nutrition versus corticosteroids in paediatric patients with Crohn's disease
|
Hojsak, I.
|
|
|
3 |
1 |
p. S61
|
artikel
|
| 110 |
P249 - Epidemiology and clinical characteristic of Crohn's disease in Polish population – preliminary data
|
Witanowska, A.
|
|
|
3 |
1 |
p. S109-S110
|
artikel
|
| 111 |
P256 - Epidemiology of inflammatory bowel diseases in northwestern Greece for the years 1981 2007
|
Zois, C.
|
|
|
3 |
1 |
p. S112
|
artikel
|
| 112 |
Perception of improved state of health and subjective quality of life in Crohn's disease patients treated with Infliximab
|
Banovic, Ingrid
|
|
|
3 |
1 |
p. 25-31
|
artikel
|
| 113 |
P230 - Ethnic differences in the genetic susceptibility to Crohn's disease: functional PPARγ gene variants are not associated with susceptibility to inflammatory bowel disease in the German population
|
Seiderer, J.
|
|
|
3 |
1 |
p. S101
|
artikel
|
| 114 |
P247 - Evidence for significant overlap between common risk variants for Crohn's disease and ankylosing spondylitis
|
Georges, M.
|
|
|
3 |
1 |
p. S109
|
artikel
|
| 115 |
P077 - Evolution of the lesions related to Crohn's disease recurrence as assessed by ultrasonography: a prospective longitudinal study
|
Calabrese, E.
|
|
|
3 |
1 |
p. S41
|
artikel
|
| 116 |
P122 - Experience with interferon-b-1a (AVONEX) and future steps for a novel approach to the treatment of moderate to severe ulcerative colitis
|
Mannon, P.J.
|
|
|
3 |
1 |
p. S59
|
artikel
|
| 117 |
P311 - Expression of factors induced under hypoxic conditions (hypoxia inducible factors HIF1α/HIF2α) in patients with Crohn's disease and ischemic colitis
|
Theodoropoulou, A.
|
|
|
3 |
1 |
p. S133
|
artikel
|
| 118 |
P264 - Extra-intestinal manifestations in IBD are associated with specific mucosal inflammatory genes expression profiles
|
Diculescu, M.M.
|
|
|
3 |
1 |
p. S115
|
artikel
|
| 119 |
P082 - Fabrication and assessment of microspheres loaded with anti-TNF-α as a prospective novel treatment for Crohn's disease fistulae
|
Day, R.
|
|
|
3 |
1 |
p. S43
|
artikel
|
| 120 |
P048 - Factors affecting post-operative recurrence in Crohn's disease
|
Ouakaa-Kchaou, A.
|
|
|
3 |
1 |
p. S30
|
artikel
|
| 121 |
P109 - Factors associated with failing of enteral nutrition in treatment of active paediatric Crohn's disease
|
Hojsak, I.
|
|
|
3 |
1 |
p. S54
|
artikel
|
| 122 |
P287 - Factors promoting inflammation-induced fibrosis in Crohn's disease
|
Whiting, C.V.
|
|
|
3 |
1 |
p. S123-S124
|
artikel
|
| 123 |
P039 - Faecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse
|
Gisbert, J.P.
|
|
|
3 |
1 |
p. S26-S27
|
artikel
|
| 124 |
P041 - Faecal Calprotectin home test in ulcerative colitis — is it possible?
|
Elkjær, M.
|
|
|
3 |
1 |
p. S27
|
artikel
|
| 125 |
P280 - Faecal calprotectin remains stable in inactive Crohn's disease patients
|
Kallel, L.
|
|
|
3 |
1 |
p. S121
|
artikel
|
| 126 |
P315 - Fecal biomarkers as assessment of inflammatory bowel disease activity
|
Vieira Sr., A.
|
|
|
3 |
1 |
p. S134
|
artikel
|
| 127 |
P195 - Fecal TNF-α as a non-invasive marker monitoring IFX maintenance therapy in IBD children
|
Sladek, M.
|
|
|
3 |
1 |
p. S87
|
artikel
|
| 128 |
P196 - Fertility and outcomes of pregnancies fathered by male patients exposed to thiopurines
|
Teruel, C.
|
|
|
3 |
1 |
p. S87-S88
|
artikel
|
| 129 |
P270 - Fibroblast activation protein expression in Crohn's disease strictures
|
Rovedatti, L.
|
|
|
3 |
1 |
p. S117
|
artikel
|
| 130 |
P007 - Fistula associated carcinoma in Crohn's disease
|
Vogelsang, H.
|
|
|
3 |
1 |
p. S13-S14
|
artikel
|
| 131 |
P084 - Fistula healing with adalimumab treatment in bioloigic-naive and anti-TNF-experienced patients with Crohn's disease: results of the CARE trial
|
Lofberg, R.
|
|
|
3 |
1 |
p. S44
|
artikel
|
| 132 |
P163 - Fistulizing Crohn's disease
|
Semianów-Wejchert, J.
|
|
|
3 |
1 |
p. S75
|
artikel
|
| 133 |
P105 - Folate and B12 vitamin deficiency in Crohn's disease: prospective controlled analysis of their prevalence and risk factors
|
Bermejo, F.
|
|
|
3 |
1 |
p. S52-S53
|
artikel
|
| 134 |
P289 - FoxP3+CD4+ cells in patients with inflammatory bowel disease (IBD) treated with anti TNFα agents
|
Guidi, L.
|
|
|
3 |
1 |
p. S124
|
artikel
|
| 135 |
P045 - Frequency and clinical impact of incidental findings at MRI of the small bowel in patients with suspected and known Crohn's disease
|
Jensen, M.D.
|
|
|
3 |
1 |
p. S28-S29
|
artikel
|
| 136 |
P137 - Functional results of IPAA for ulcerative colitis after postoperative pelvic complications
|
Selvaggi, F.
|
|
|
3 |
1 |
p. S65
|
artikel
|
| 137 |
P238 - Functional Toll-like receptor 5 gene variants are not associated with susceptibility to inflammatory bowel disease in the German population
|
Seiderer, J.
|
|
|
3 |
1 |
p. S105
|
artikel
|
| 138 |
P304 - Galectin-2 and galectin-4 modulate intestinal wound healing, induce T cell apoptosis and thus ameliorate intestinal inflammation in an experimental model of murine colitis
|
Paclik, D.
|
|
|
3 |
1 |
p. S130
|
artikel
|
| 139 |
P130 - Gastrointestinal selectivity of vedolizumab (MLN0002), a humanized monoclonal antibody to α 4β 7 integrin
|
Parikh, A.
|
|
|
3 |
1 |
p. S62
|
artikel
|
| 140 |
P257 - Genetic association between Crohn's disease and a marker located in the region of claudin 2 implicates the intestinal barrier as a primary risk factor in a Swedish population
|
Slånemyr, E.
|
|
|
3 |
1 |
p. S112-S113
|
artikel
|
| 141 |
P263 - Genetic polymorphisms of thiopurine methyltransferase in Croatian inflammatory bowel disease patients
|
Ladic, A.
|
|
|
3 |
1 |
p. S114-S115
|
artikel
|
| 142 |
P217 - Genetic variants in autophagy related genes and granuloma formation in patients with Crohn's disease
|
Brinar, M.
|
|
|
3 |
1 |
p. S96
|
artikel
|
| 143 |
P144 - Genitointestinal fistulas in Crohn's disease. Clinical characteristics and response to therapy
|
De La Poza, G.
|
|
|
3 |
1 |
p. S68
|
artikel
|
| 144 |
P117 - Global safety of adalimumab in trials of patients with Crohn's disease
|
Colombel, J.F.
|
|
|
3 |
1 |
p. S57
|
artikel
|
| 145 |
P278 - Granulocyte macrophage colony stimulating factor improves mucosal repair in a mouse model of acute colitis
|
Bernasconi, E.
|
|
|
3 |
1 |
p. S120
|
artikel
|
| 146 |
P185 - Granulocyte, monocyte adsorptive (GMA) apheresis in UC: is the treatment efficacy dose-dependent? Results of a randomized comparison of 5 versus 10, the CESA 5.10 study
|
Dignass, A.
|
|
|
3 |
1 |
p. S83
|
artikel
|
| 147 |
P046 - Health-related quality of life in patients with IBD Comparing groups with short-and long-term disease duration
|
Jäghult, S.
|
|
|
3 |
1 |
p. S29
|
artikel
|
| 148 |
P169 - Higher remission rates in patients with once-daily dosing compared to twice-daily dosing. An analysis of compliance in the once daily vs. twice daily podium trial with mesalazine (Pentasa®) sachets
|
Bokemeyer, B.
|
|
|
3 |
1 |
p. S78
|
artikel
|
| 149 |
P226 - High incidence of Crohn's disease in Western Hungary between 2002 2006
|
Lakatos, L.
|
|
|
3 |
1 |
p. S100
|
artikel
|
| 150 |
P283 - High prevalence of P-ANCA in ulcerative colitis and primary sclerosing cholangiitis. Results of analyses with lactoferrin-repleted granulocytes
|
Komorowski, L.
|
|
|
3 |
1 |
p. S122
|
artikel
|
| 151 |
P180 - High sensitivity C-reactive protein in paediatric patients with inflammatory bowel disease
|
Vihinen, M.
|
|
|
3 |
1 |
p. S81
|
artikel
|
| 152 |
P174 - How often does infliximab lose its effect and dose intensification is required? A review
|
Gisbert, J.P.
|
|
|
3 |
1 |
p. S79-S80
|
artikel
|
| 153 |
P151 - How variable is the Mayo score between observers and might this affect trial recruitment or outcome?
|
Walsh, A.J.
|
|
|
3 |
1 |
p. S71
|
artikel
|
| 154 |
P274 - Hydrocortisone and noradrenaline down-regulate the expression of the constitutively expressed colonic epithelial antibacterial peptides
|
Javaid, A.
|
|
|
3 |
1 |
p. S119
|
artikel
|
| 155 |
P188 - IBD care in Europe: a comparative audit of Crohn's disease care between Oxford and Milan using the validated National UK IBD Audit Tool
|
Cassinotti, A.
|
|
|
3 |
1 |
p. S84
|
artikel
|
| 156 |
P204 - IBD care in Europe: a comparative audit of ulcerative colitis care between Oxford and Milan using the validated National UK IBD Audit Tool
|
Cassinotti, A.
|
|
|
3 |
1 |
p. S91
|
artikel
|
| 157 |
P114 - IL-10 and loss of response to anti-TNF-α agents in inflammatory bowel disease patients
|
Dorofeyev, A.
|
|
|
3 |
1 |
p. S55-S56
|
artikel
|
| 158 |
P291 - IL-2 enhances the in vitro proliferation of T cells from patients with IBD but does not influence in vitro steroid resistance
|
Williams, A.M.
|
|
|
3 |
1 |
p. S125
|
artikel
|
| 159 |
P232 - Immunosuppressant therapy for Crohn's disease: higher need or better awareness? – The experience of a Romanian tertiary referral centre
|
Catuneanu, A.
|
|
|
3 |
1 |
p. S102
|
artikel
|
| 160 |
P244 - Impact of biliary and nutritional lack of phospholipids in a colitis mouse model
|
Jahnel, J.
|
|
|
3 |
1 |
p. S107-S108
|
artikel
|
| 161 |
P062 - Impact of capsule endoscopy in the management of patients with inflammatory bowel disease
|
Márquez, L.
|
|
|
3 |
1 |
p. S35
|
artikel
|
| 162 |
P126 - Implementation of a day care unit for inflammatory bowel disease: patients' satisfaction
|
Martín-Arranz, M.
|
|
|
3 |
1 |
p. S60-S61
|
artikel
|
| 163 |
P254 - Incidence of nonspecific ulcerative colitis in Republic of Tatarstan (first Russian inflammatory bowel diseases registry)
|
Abdulkhakov, R.A.
|
|
|
3 |
1 |
p. S111
|
artikel
|
| 164 |
P059 - Incidence of pre-malignant lesions in patients with long standing ulcerative colitis
|
Gordillo, J.
|
|
|
3 |
1 |
p. S34
|
artikel
|
| 165 |
P111 - Incidence, risk factors and clinical course of gastrointestinal intolerance in inflammatory bowel disease patients treated with azathioprine: the role of TPMT
|
Bastida, G.
|
|
|
3 |
1 |
p. S54-S55
|
artikel
|
| 166 |
P094 - Increased antigenic uptake in patients with ulcerative colitis role of CRH and muscarinic receptors
|
Wallon, C.
|
|
|
3 |
1 |
p. S48
|
artikel
|
| 167 |
P307 - Increased intestinal vascular endothelial growth factor expression and mucosal vascularization in patients with spondylarthropathy
|
Hindryckx, P.
|
|
|
3 |
1 |
p. S131
|
artikel
|
| 168 |
P131 - Induction and maintenance of clinical response and remission with certolizumab pegol in patients with inflammatory or fistulizing Crohn's disease: a referral center experience of compassionate use
|
Mocciaro, F.
|
|
|
3 |
1 |
p. S63
|
artikel
|
| 169 |
P265 - Induction and modulation of T cell regulatory function by intestinal fibroblasts: inhibitory effect of intestinal inflammation
|
Scaldaferri IV, F.
|
|
|
3 |
1 |
p. S115
|
artikel
|
| 170 |
P053 - Inflammatory bowel disease in the elderly. A comparison with young adults
|
Ben Hriz, F.
|
|
|
3 |
1 |
p. S31
|
artikel
|
| 171 |
P260 - Inflammatory bowel disease patients referred to the tertiary center in Republic of Tatarstan, Russia
|
Abdulganieva, D.
|
|
|
3 |
1 |
p. S113-S114
|
artikel
|
| 172 |
P227 - Inflammatory genes expression profiles in patients with IBD investigated using multiplex ligation-dependent probe amplification (MLPA)
|
Diculescu, M.M.
|
|
|
3 |
1 |
p. S100
|
artikel
|
| 173 |
P212 - Infliximab as a treatment for ulcerative colitis – 3½ years experience in a district general hospital
|
Taylor, K.
|
|
|
3 |
1 |
p. S94
|
artikel
|
| 174 |
P207 - Infliximab use in adolescents with IBD
|
Goodhand, J.
|
|
|
3 |
1 |
p. S92
|
artikel
|
| 175 |
P125 - Influence of disease duration on adalimumab efficacy in Crohn's disease: subanalysis of the CARE trial
|
Reinisch, W.
|
|
|
3 |
1 |
p. S60
|
artikel
|
| 176 |
P296 - Influence of Schistosoma mansoni and its soluble egg antigen on DSS-induced colitis in mice
|
Bodammer, P.
|
|
|
3 |
1 |
p. S127
|
artikel
|
| 177 |
P143 - Influence of smoking on azathioprine efficacy in steroid-dependent inflammatory bowel disease
|
Carrión, S.
|
|
|
3 |
1 |
p. S67-S68
|
artikel
|
| 178 |
P064 - Influence of smoking on the clinical outcome of new-onset Crohn's disease
|
Zabana, Y.
|
|
|
3 |
1 |
p. S36
|
artikel
|
| 179 |
P302 - Innate immune suppression by trace metals – an unexpected role in the pathogenesis of Crohn's disease?
|
Ben-Horin, S.
|
|
|
3 |
1 |
p. S129
|
artikel
|
| 180 |
P157 - Intensification of infliximab (IFX) therapy in Crohn's disease: efficacy and safety
|
Chaparro, M.
|
|
|
3 |
1 |
p. S73
|
artikel
|
| 181 |
P113 - Interactions among treatment trends, quality of life and disease activity in inflammatory bowel disease (IBD)
|
Andrews, J.M.
|
|
|
3 |
1 |
p. S55
|
artikel
|
| 182 |
P271 - Interactions between pro-inflammatory cytokines and IL-13 during the development of intestinal strictures
|
Bailey, J.R.
|
|
|
3 |
1 |
p. S117-S118
|
artikel
|
| 183 |
P112 - Intestinal surgery for Crohn's disease: predictors of recovery, complications and health related quality of life
|
Scarpa, M.
|
|
|
3 |
1 |
p. S55
|
artikel
|
| 184 |
P024 - Involving IBD patients into the Enhanced Recovery Programme
|
Vasas, P.
|
|
|
3 |
1 |
p. S20-S21
|
artikel
|
| 185 |
P172 - In what proportion of IBD patients coming to resection surgery was there an opportunity to optimise preoperative care? A one year audit of a tertiary referral hospital
|
Gapasin, J.
|
|
|
3 |
1 |
p. S79
|
artikel
|
| 186 |
P189 - Is inosine-5′-monophosphate dehydrogenase of importance in thiopurine treated patients who display a “skewed” metabolite profile?
|
Haglund, S.
|
|
|
3 |
1 |
p. S84-S85
|
artikel
|
| 187 |
P002 - Is low grade dysplasia always a predictor of cancer in ulcerative colitis?
|
Merlini, N.
|
|
|
3 |
1 |
p. S11
|
artikel
|
| 188 |
P197 - Is the clinical course of UC different in Turkey?
|
Dağlli, erÜ
|
|
|
3 |
1 |
p. S88
|
artikel
|
| 189 |
P193 - I219V polymorphism in hMLH1 gene in patients affected with ulcerative colitis
|
Riegler, G.
|
|
|
3 |
1 |
p. S86-S87
|
artikel
|
| 190 |
P237 - Knowledge of the investigation and management of patients who have undergone pouch surgery is lacking in gastroenterology trainees
|
McLaughlin, S.D.
|
|
|
3 |
1 |
p. S104
|
artikel
|
| 191 |
P221 - Lack of association of previously identified disease loci 10q12, 11p15, and 20q13 in IBD
|
Latiano, A.
|
|
|
3 |
1 |
p. S98
|
artikel
|
| 192 |
P009 - Liver fibrosis evaluation by transient elastography (Fibroscan®) in patients with inflammatory bowel disease (IBD) treated with methotrexate (MTX): a multicenter trial
|
Barbero, A.
|
|
|
3 |
1 |
p. S15
|
artikel
|
| 193 |
P297 - Local fuelling of IL-2 determines the tissue localisation of CD4+Foxp3+ regulatory T cells – proliferating cells signal inflammation and provide IL-2
|
Händel, N.
|
|
|
3 |
1 |
p. S127-S128
|
artikel
|
| 194 |
P241 - Loci at chr21q22 and MHC are associated to UC in Italian population
|
Palmieri, O.
|
|
|
3 |
1 |
p. S106
|
artikel
|
| 195 |
P166 - Long term colectomy rate in steroid responder and steroid-dependent, cyclosporine treated patients
|
Molnár, T.
|
|
|
3 |
1 |
p. S76-S77
|
artikel
|
| 196 |
P208 - Long-term durability of infliximab (IFX) treatment in Crohn's disease (CD) and efficacy of dose “intensification” in patients losing response
|
Chaparro, M.
|
|
|
3 |
1 |
p. S93
|
artikel
|
| 197 |
P186 - Long-term prevention of post-operative recurrence in Crohn's disease is not affected by mesalamine
|
Aratari Jr., A.
|
|
|
3 |
1 |
p. S83-S84
|
artikel
|
| 198 |
P096 - Long term results of treatment of perianal fistulas in IBD patients by advancement flap
|
Serclova, Z.
|
|
|
3 |
1 |
p. S48-S49
|
artikel
|
| 199 |
P108 - Long term study for evaluating the clinical efficacy and mucosal healing rate of infliximab in steroid-dependent ulcerative colitis
|
Barreiro, M.
|
|
|
3 |
1 |
p. S53-S54
|
artikel
|
| 200 |
P279 - Low dose administration of cytokines and antibodies for the treatment of Crohn's disease
|
Zanobbio, L.
|
|
|
3 |
1 |
p. S120-S121
|
artikel
|
| 201 |
P175 - Low endothelial progenitor cell numbers in patients with inflammatory bowel disease
|
Checchin, D.
|
|
|
3 |
1 |
p. S80
|
artikel
|
| 202 |
P005 - Low frequency of IBD-related colorectal carcinoma in non-tertiary centers: final results of a nation wide long-term survey
|
Baars, J.E.
|
|
|
3 |
1 |
p. S12-S13
|
artikel
|
| 203 |
P073 - Luminal vs extraluminal findings compatible with Crohn's disease recurrence: prospective longitudinal study 3 years after surgery
|
Onali, S.
|
|
|
3 |
1 |
p. S39
|
artikel
|
| 204 |
P176 - Maintenance therapy with infliximab in corticosteroid-dependent patients with ulcerative colitis (preliminary results)
|
Maldonado-Pérez, B.
|
|
|
3 |
1 |
p. S80
|
artikel
|
| 205 |
P273 - Mannose-binding lectin (MBL) deficiency is associated with complicated Crohn's disease in patients, and more severe colitis in mice
|
Seibold, F.
|
|
|
3 |
1 |
p. S118
|
artikel
|
| 206 |
P295 - MBL level and deficiency is not associated with either Crohn's disease or ulcerative colitis, disease phenotype, CRP, serology profile and NOD2/CARD15 genotype in a large Hungarian IBD cohort, but was associated to the lack of TLR4 variants in CD
|
Papp, M.
|
|
|
3 |
1 |
p. S127
|
artikel
|
| 207 |
P065 - Medina catheter use following restorative proctocolectomy for ulcerative colitis: quality of life and functional outcome
|
McLaughlin, S.D.
|
|
|
3 |
1 |
p. S36
|
artikel
|
| 208 |
P236 - MEFV mutations modify the disease severity of inflammatory bowel disease
|
Barghi, I.
|
|
|
3 |
1 |
p. S104
|
artikel
|
| 209 |
P103 - Mesenchymal stem cells administered via novel selective mesenteric artery cannulation for the treatment of severe refractory Crohn's disease
|
Dinesen, L.
|
|
|
3 |
1 |
p. S51-S52
|
artikel
|
| 210 |
P085 - Mesenchymal stem cells are effective for mucosal healing in ulcerative colitis and Crohn's disease
|
Lazebnik, L.
|
|
|
3 |
1 |
p. S44-S45
|
artikel
|
| 211 |
P021 - Microalbuminuria in inflammatory bowel disease. Prevalence and significance
|
Ben Hriz, F.
|
|
|
3 |
1 |
p. S19-S20
|
artikel
|
| 212 |
P323 - Molecular analysis of colonic microbiota in patients with ulcerative colitis
|
Foruny, J.
|
|
|
3 |
1 |
p. S137
|
artikel
|
| 213 |
P231 - Month of birth and the occurrence of Crohn's disease
|
Angelucci, E.
|
|
|
3 |
1 |
p. S102
|
artikel
|
| 214 |
P014 - MR enterography an accurate tool in detection of inflammations activity in patients with Crohn's disease
|
Mankowska-Wierzbicka, D.
|
|
|
3 |
1 |
p. S16-S17
|
artikel
|
| 215 |
P317 - Mucosa-associated Escherichia coli and Faecalibacterium prausnitzii quantification by real-time PCR and its potential use as complementary diagnostic tool for inflammatory bowel diseases
|
Lopez-Siles, M.
|
|
|
3 |
1 |
p. S135
|
artikel
|
| 216 |
P031 - Mucosal healing and risk of colectomy in ulcerative colitis patients
|
Papa, A.
|
|
|
3 |
1 |
p. S23
|
artikel
|
| 217 |
P285 - Mucosal nonimmune cells produce pro-inflammatory mediators in response to Toll-like (TLRs) and Nod-like receptor (NLRs) ligands: mesenchymal and endothelial cells as novel players of intestinal innate immunity
|
Scaldaferri IV, F.
|
|
|
3 |
1 |
p. S122-S123
|
artikel
|
| 218 |
P110 - Multifocal motor neuropathy with conduction block related to infliximab in Crohn's disease
|
Kotze, P.G.
|
|
|
3 |
1 |
p. S54
|
artikel
|
| 219 |
P266 - Murine DSS colitis as model for exploring mesenchymal stem cell therapy in inflammatory bowel disease
|
Flöckner, K.
|
|
|
3 |
1 |
p. S116
|
artikel
|
| 220 |
P314 - Mycological stool examination, anti-Candida mannan antibodies and serum concentration of interleukin 10 in ulcerative colitis
|
Ksiądzyna, D.
|
|
|
3 |
1 |
p. S134
|
artikel
|
| 221 |
P074 - Myenteric plexitis does not predict endoscopic Crohn's disease recurrence 12 months following ileo-colonic resection in district general hospital practice
|
Blaker, P.A.
|
|
|
3 |
1 |
p. S40
|
artikel
|
| 222 |
P071 - Mythbusters: normal-looking ileocecal valve does not exclude Crohn's disease in the terminal ileum
|
Farkas, K.
|
|
|
3 |
1 |
p. S39
|
artikel
|
| 223 |
P115 - Neoplasia within 10 years of diagnosis of ulcerative colitis
|
Checchin, D.
|
|
|
3 |
1 |
p. S56
|
artikel
|
| 224 |
P161 - Newly diagnosed neoplasia in a cohort of Crohn's disease patients treated or untreated with infliximab followed up in the long term: a multicenter matched-pair study
|
Biancone, L.
|
|
|
3 |
1 |
p. S74
|
artikel
|
| 225 |
P067 - Nitric oxide (NO) production decreases after prednisone administration in corticosteroid-sensitive patients with ulcerative colitis and does not change in corticosteroid-resistant ones
|
Baryshnikov, E.
|
|
|
3 |
1 |
p. S37
|
artikel
|
| 226 |
P215 - Novel association of the interleukin 2 interleukin 21 region with inflammatory bowel disease
|
Mendoza, J.L.
|
|
|
3 |
1 |
p. S95
|
artikel
|
| 227 |
P098 - Optimizing treatment of perianal fistulae in Crohn's disease results from an interdisciplinary approach
|
Strauch, U.
|
|
|
3 |
1 |
p. S49-S50
|
artikel
|
| 228 |
P142 - Oral and intravenous iron treatment in inflammatory bowel disease: haematological response and quality of life improvement
|
Gisbert, J.P.
|
|
|
3 |
1 |
p. S67
|
artikel
|
| 229 |
P127 - Oral cyclosporin vs infliximab in patients with severe ulcerative colitis refractory to iv steroids. Preliminary data of a controlled, randomized study
|
Bossa, F.
|
|
|
3 |
1 |
p. S61
|
artikel
|
| 230 |
P054 - Osteoporosis in Crohn's disease: Who is to blame?
|
Fidalgo, C.
|
|
|
3 |
1 |
p. S32
|
artikel
|
| 231 |
Potential role of protease-activated receptor-2-stimulated activation of cytosolic phospholipase A2 in intestinal myofibroblast proliferation: Implications for stricture formation in Crohn's disease
|
Christerson, Ulrika
|
|
|
3 |
1 |
p. 15-24
|
artikel
|
| 232 |
P205 - Outcome of patients with Crohn's disease and primary sclerosing cholangitis in CHARM and GAIN
|
Panaccione, R.
|
|
|
3 |
1 |
p. S91-S92
|
artikel
|
| 233 |
P222 - Overall and cause-specific mortality in Crohn's disease: a meta-analysis of population-based studies
|
Duricova Jr., D.
|
|
|
3 |
1 |
p. S98
|
artikel
|
| 234 |
P219 - Overall and organ-specific extra-intestinal cancer in inflammatory bowel disease: a meta-analysis of population-based studies
|
Pedersen Jr., N.
|
|
|
3 |
1 |
p. S97
|
artikel
|
| 235 |
P015 - Pancreatic autoantibodies are associated with reactivity to microbial antibodies penetrating disease behavior perianal disease and extraintestinal manifestations but not with NOD2/CARD15 or TLR4 genotype in a Hungarian IBD cohort
|
Lakatos, P.L.
|
|
|
3 |
1 |
p. S17
|
artikel
|
| 236 |
P081 - Pancreatic insufficiency in inflammatory bowel disease. Assessment by fecal elastase-1
|
Rustemovic, N.
|
|
|
3 |
1 |
p. S43
|
artikel
|
| 237 |
P190 - Parenteral methotrexate for Crohn's disease: 9 years experience in a district general hospital
|
Taylor, K.
|
|
|
3 |
1 |
p. S85
|
artikel
|
| 238 |
P284 - Pathology of regulatory T cells in Crohn's disease: impaired migration of CCR4+ Treg to inflamed mucosa or insufficient priming of naive Treg in the mesenteric lymph node – or both?
|
Reichhardt, A.
|
|
|
3 |
1 |
p. S122
|
artikel
|
| 239 |
P182 - Patient perceptions of home biologic therapy – adalimumab
|
Kemp, K.
|
|
|
3 |
1 |
p. S82
|
artikel
|
| 240 |
P078 - Patient preferences for Crohn's disease flare-up therapy: a discrete choice experiment
|
Calvet, X.
|
|
|
3 |
1 |
p. S41-S42
|
artikel
|
| 241 |
P025 - Patient preferences for Crohn's disease maintenance therapy: a discrete choice experiment
|
Calvet, X.
|
|
|
3 |
1 |
p. S21
|
artikel
|
| 242 |
P162 - Patients' evaluation of dietary advice in ulcerative colitis (UC): results of a pilot study
|
Moshkovska, T.A.
|
|
|
3 |
1 |
p. S74-S75
|
artikel
|
| 243 |
P245 - Penetrance of NOD2/CARD15 genetic variants in the general population
|
Yazdanyar, S.
|
|
|
3 |
1 |
p. S108
|
artikel
|
| 244 |
P298 - Permanent catalase activity impairment due to minor expression of catalase protein in peripheral white mononuclear cells of patients with naive and treated Crohn's disease
|
Iborra, M.
|
|
|
3 |
1 |
p. S128
|
artikel
|
| 245 |
P303 - Peroxisome proliferator-activated receptor gamma (PPARγ) expression and activation in colonic epithelial cells from patients with ulcerative colitis: a randomized, controlled pilot study of the effect of topical treatment with rosiglitazone enemas
|
Pedersen, G.
|
|
|
3 |
1 |
p. S129-S130
|
artikel
|
| 246 |
P099 - Postcolectomy burden in ulcerative colitis patients undergoing colectomy
|
Taxonera, C.
|
|
|
3 |
1 |
p. S50
|
artikel
|
| 247 |
P318 - Pouchitis and bacterial flora
|
Scarpa, M.
|
|
|
3 |
1 |
p. S135-S136
|
artikel
|
| 248 |
P183 - Predictive factors for a mild course of Crohn's disease
|
Bokemeyer, B.
|
|
|
3 |
1 |
p. S82-S83
|
artikel
|
| 249 |
P187 - Predictors of response to infliximab in moderate-to-severe ulcerative colitis
|
García-Bosch, O.
|
|
|
3 |
1 |
p. S84
|
artikel
|
| 250 |
P149 - Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME study
|
Coelho, J.
|
|
|
3 |
1 |
p. S70
|
artikel
|
| 251 |
P239 - Pregnancy outcomes in women exposed to adalimumab: the OTIS autoimmune diseases in pregnancy project
|
Johnson, D.L.
|
|
|
3 |
1 |
p. S105
|
artikel
|
| 252 |
P029 - Prevalence and prognostic influence of the jejunal lesions seen by wireless capsule endoscopy in Crohn's disease patients
|
Trang, C.
|
|
|
3 |
1 |
p. S22
|
artikel
|
| 253 |
P106 - Prevalence of alterations of bone mineral density in new-onset inflammatory bowel disease and associated risk factors
|
Ortiz, T.
|
|
|
3 |
1 |
p. S53
|
artikel
|
| 254 |
P312 - Prevalence of antibodies against thyroglobulin (anti-Tg) and thyroid peroxidase (anti-TPO) in patients with inflammatory bowel disease on scheduled infliximab or conventional treatment: a two years follow up study
|
Papamichael, K.
|
|
|
3 |
1 |
p. S133
|
artikel
|
| 255 |
P233 - Prevalence of antibodies recognizing cyclic citrullinated peptides (anti-CCP) in patients with ulcerative colitis
|
Tirri, R.
|
|
|
3 |
1 |
p. S103
|
artikel
|
| 256 |
P102 - Prevention of postoperative clinical recurrence in Crohn's disease (CD) based on colonoscopy within the first year after surgery for decision of a tailored treatment
|
Baudry, C.
|
|
|
3 |
1 |
p. S51
|
artikel
|
| 257 |
P088 - Prevention of postsurgical recurrence of Crohn's disease by infliximab: a three years follow-up study
|
Sorrentino, D.
|
|
|
3 |
1 |
p. S46
|
artikel
|
| 258 |
P023 - Primary sclerosing cholangitis and inflammatory bowel disease: risk factors and prognostic value
|
Freire, P.
|
|
|
3 |
1 |
p. S20
|
artikel
|
| 259 |
P242 - Prioritization of mucosal protease/protease inhibitor candidate genes in inflammatory bowel disease through a systematic review analysis approach
|
Cleynen, I.
|
|
|
3 |
1 |
p. S107
|
artikel
|
| 260 |
P047 - Prospective assessment of the effect on quality of life of healing perineal Crohn's fistulas with anti-tumour necrosis factor therapy
|
Ng, S.C.
|
|
|
3 |
1 |
p. S29
|
artikel
|
| 261 |
P051 - Prospective study of contrast-enhanced small bowel sonography (CES) in patients with Crohn's disease (CD) operated of an ileal stenosis. Preliminary results
|
Quencez, L.
|
|
|
3 |
1 |
p. S31
|
artikel
|
| 262 |
P037 - Pseudopolyposis in inflammatory bowel disease: prevalence in a tertiary referral center
|
Markoš Jr., P.
|
|
|
3 |
1 |
p. S25-S26
|
artikel
|
| 263 |
P018 - Psychopathological features of patients with ulcerative colitis Crohn's disease and irritable bowel syndrome
|
Piacentino, D.
|
|
|
3 |
1 |
p. S18
|
artikel
|
| 264 |
P020 - RDW — a new diagnostic and activity marker for inflammatory bowel disease
|
Szepes, Z.G.
|
|
|
3 |
1 |
p. S19
|
artikel
|
| 265 |
P040 - Reduced muscle mass and bone size in pediatric patients with inflammatory bowel disease
|
Bechthold, S.
|
|
|
3 |
1 |
p. S27
|
artikel
|
| 266 |
P095 - Reducing the time to symptom improvement and resolution for moderately active UC
|
Orchard, T.R.
|
|
|
3 |
1 |
p. S48
|
artikel
|
| 267 |
P061 - Reduction in extraintestinal manifestations of Crohn's disease is associated with improvements in patient-reported and disease activity outcomes in patients treated with adalimumab
|
Reinisch, W.
|
|
|
3 |
1 |
p. S35
|
artikel
|
| 268 |
P203 - Reduction of disease activity during long time course of ulcerative colitis
|
Emmrich, J.
|
|
|
3 |
1 |
p. S90-S91
|
artikel
|
| 269 |
P234 - Relationship between CARD15 single nucleotide polymorphisms and gene expression level
|
Sadakierska-Chudy, A.
|
|
|
3 |
1 |
p. S103
|
artikel
|
| 270 |
P089 - Results from a prospective study combining infliximab, surgery, and methotrexate in severe fistulising ano-perineal Crohn's disease
|
Roumeguère, P.
|
|
|
3 |
1 |
p. S46
|
artikel
|
| 271 |
P224 - Results of association analysis of markers from recent genome wide association scans (GWAS) with inflammatory bowel disease in Lithuanian population
|
Sventoraityte, J.
|
|
|
3 |
1 |
p. S99
|
artikel
|
| 272 |
P138 - Retrospective study of outcomes of patients with Crohn's disease treated with early immunosuppression
|
Taylor, K.
|
|
|
3 |
1 |
p. S66
|
artikel
|
| 273 |
P308 - Rifamycin SV: evaluation of the activity in DNB-induced colitis in rats and on IFNγ production in ConA-stimulated rat splenocytes
|
Quattrocchi, C.
|
|
|
3 |
1 |
p. S131-S132
|
artikel
|
| 274 |
P033 - Risk of Crohn's disease-related hospitalization in patients receiving long-term adalimumab therapy: 3-year data from CHARM and ADHERE
|
Loftus Jr., E.V.
|
|
|
3 |
1 |
p. S24
|
artikel
|
| 275 |
P261 - Risk, predictors, results and rate of colectomy in a historical ulcerative colitis cohort
|
Saro Gismera IV, C.
|
|
|
3 |
1 |
p. S114
|
artikel
|
| 276 |
P104 - Safety and efficacy of adalimumab in a patient with refractory Crohn's disease and previous severe infliximab hepatotoxicity. A case report
|
Puig, I.
|
|
|
3 |
1 |
p. S52
|
artikel
|
| 277 |
P120 - Safety and efficacy of total dose infusion of low molecular weight iron dextran for iron deficiency anemia in patients with inflammatory bowel disease
|
Oustamanolakis, P.
|
|
|
3 |
1 |
p. S58
|
artikel
|
| 278 |
P158 - Safety of once daily versus twice daily dosing with mesalazine (Pentasa®) sachets. Results from a 12 month randomised controlled trial in maintenance of remission of ulcerative colitis
|
Dignass, A.
|
|
|
3 |
1 |
p. S73
|
artikel
|
| 279 |
P066 - Sclerosing cholangitis and microscopic colitis: pediatric sub-entity?
|
Gonçalves, C.
|
|
|
3 |
1 |
p. S36-S37
|
artikel
|
| 280 |
P100 - Selective glucocorticoid receptor agonists (SEGRA's), a new therapeutic option in inflammatory bowel disease?!
|
Reuter, K.C.
|
|
|
3 |
1 |
p. S50
|
artikel
|
| 281 |
P258 - Serotonin transporter gene polymorphisms in Crohn's disease patients
|
Grubelic Ravic, K.
|
|
|
3 |
1 |
p. S113
|
artikel
|
| 282 |
P269 - Serum pro-inflammatory cytokine concentrations in patients with Crohn's disease and osteoporosis
|
Zavos, C.
|
|
|
3 |
1 |
p. S117
|
artikel
|
| 283 |
P210 - Severe ulcerative colitis (UC) and progressive relapsing multiple sclerosis (PRMS): Report of a case
|
Hadad, Y.
|
|
|
3 |
1 |
p. S93-S94
|
artikel
|
| 284 |
P165 - Sex lives in IBD outpatients
|
Bucci, C.
|
|
|
3 |
1 |
p. S76
|
artikel
|
| 285 |
P276 - SGLT-1 activation, a new approach to Crohn's disease
|
Dusio, G.F.
|
|
|
3 |
1 |
p. S119-S120
|
artikel
|
| 286 |
P275 - Simvastatin reduces the proliferation and adhesion of intestinal colon lamina propria fibroblasts (CLPF) from fibrotic mucosa of patients with Crohn's disease and modulates the Smad3-mediated TGF-β 1 pathway
|
Schmidt, J.
|
|
|
3 |
1 |
p. S119
|
artikel
|
| 287 |
P267 - Smad7 controls resistance of colitogenic T cells to regulatory T cell-mediated suppression
|
Fantini, M.
|
|
|
3 |
1 |
p. S116
|
artikel
|
| 288 |
P043 - Small bowel involvement in Crohn's disease: a prospective study comparing wireless capsule endoscopy and magnetic resonance enteroclysis
|
Pica, R.
|
|
|
3 |
1 |
p. S28
|
artikel
|
| 289 |
P243 - Small intestine contrast ultrasonography for detecting asymptomatic small bowel Crohn's disease lesions: a family study
|
Calabrese, E.
|
|
|
3 |
1 |
p. S107
|
artikel
|
| 290 |
P058 - Small intestine contrast ultrasonography (SICUS): an alternative to radiology in the assessment of small bowel disease in pediatric patients with Crohn's disease
|
Pallotta, N.
|
|
|
3 |
1 |
p. S33-S34
|
artikel
|
| 291 |
P087 - SONIC: a randomized, double-blind, controlled trial comparing infliximab and infliximab plus azathioprine to azathioprine in patients with Crohn's disease naive to immunomodulators and biologic therapy
|
Colombel, J.F.
|
|
|
3 |
1 |
p. S45-S46
|
artikel
|
| 292 |
P004 - Specialist transitional clinics for adolescents with IBD limit exposure to diagnostic radiation
|
Goodhand, J.
|
|
|
3 |
1 |
p. S12
|
artikel
|
| 293 |
P201 - Sphincter repair for faecal incontinence in Crohn's disease with associated sphincter defect and complex perianal fistula
|
Alvarez, J.A.
|
|
|
3 |
1 |
p. S89-S90
|
artikel
|
| 294 |
P218 - Stability of granuloma formation over time in patients with Crohn's disease and the relationship with variants in autophagy genes
|
Brinar, M.
|
|
|
3 |
1 |
p. S96-S97
|
artikel
|
| 295 |
P083 - Steroid-free remission in patients with Crohn's disease who received adalimumab therapy for at least 3 years: long-term results from CHARM
|
Kamm, M.A.
|
|
|
3 |
1 |
p. S43-S44
|
artikel
|
| 296 |
P006 - Sustainability of adalimumab in improving the quality of life of patients with fistulizing Crohn's disease: 3-year data from CHARM
|
Schwartz, D.A.
|
|
|
3 |
1 |
p. S13
|
artikel
|
| 297 |
P306 - Targeting angiogenesis in colitis-associated cancer
|
Waldner, M.
|
|
|
3 |
1 |
p. S131
|
artikel
|
| 298 |
P292 - TGF-β 1 induces the differentiation of colon lamina propria fibroblasts (CLPF) into myofibroblasts in vitro
|
Bechler, A.
|
|
|
3 |
1 |
p. S125
|
artikel
|
| 299 |
P055 - The ACCESS trial: impact of adalimumab on remission, response and quality of life in patients with Crohn's disease
|
Panaccione, R.
|
|
|
3 |
1 |
p. S32
|
artikel
|
| 300 |
P003 - The ACCESS trial: impact of adalimumab on steroid-free remission and fistula closure in patients with Crohn's disease
|
Panaccione, R.
|
|
|
3 |
1 |
p. S11-S12
|
artikel
|
| 301 |
P293 - The bacterial colonisation of the gut mediates trafficking of luminal antigens into MHC Class II-enriched compartments in intestinal epithelial cells
|
Möller, N.
|
|
|
3 |
1 |
p. S126
|
artikel
|
| 302 |
P069 - The CARE trial: adalimumab improves work productivity and quality of life in patients with Crohn's disease
|
Louis, E.
|
|
|
3 |
1 |
p. S38
|
artikel
|
| 303 |
P214 - The changing pattern of Crohn's disease incidence according to age in Northern France: a constant increase in the 0 19 years age group (1988 2005)
|
Chouraki, V.
|
|
|
3 |
1 |
p. S95
|
artikel
|
| 304 |
P034 - The effect of inflammatory bowel disease (IBD) during pregnancy on long term health and illness in children of patients — a multicenter Israeli study
|
Dotan, I.
|
|
|
3 |
1 |
p. S24
|
artikel
|
| 305 |
P310 - The effect of infliximab treatment on angiogenic factors levels in patients with inflammatory bowel disease
|
Algaba, A.
|
|
|
3 |
1 |
p. S132-S133
|
artikel
|
| 306 |
P121 - The efficacy and safety of cyclosporine (CSA) and infliximab (IFX) in colitis ulcerosa (CU). Results in IBD-HOT follow-up study
|
Nieminen, U.
|
|
|
3 |
1 |
p. S58-S59
|
artikel
|
| 307 |
P216 - The first two Crohn's disease susceptibility loci with a high degree of epistasis: PTGER4-expression-modulating polymorphisms in the 5p13.1 region enhance ATG16L1-associated susceptibility to Crohn's disease
|
Seiderer, J.
|
|
|
3 |
1 |
p. S96
|
artikel
|
| 308 |
P129 - The impact of concomitant treatment with immuno-modulators and antibiotics on the outcome of C. difficile-associated inflammatory bowel disease exacerbation: an ECCO multi-center retrospective study
|
Ben-Horin, S.
|
|
|
3 |
1 |
p. S62
|
artikel
|
| 309 |
P068 - The incidence of adenomatous polyp dysplasia and colon cancer in ulcerative colitis
|
Kekilli, M.
|
|
|
3 |
1 |
p. S37-S38
|
artikel
|
| 310 |
P229 - The influence of eicosapentaenoic acid (EPA) on TNF-α production by peripheral blood mononuclear cells of Crohn's disease (CD) patients and cell kinetics accordingly to TNF-α −857C/T polymorphism
|
Ferreira, P.
|
|
|
3 |
1 |
p. S101
|
artikel
|
| 311 |
P305 - The molecular mechanism of action of anti-TNF antibodies in inflammatory bowel diseases
|
Atreya, R.
|
|
|
3 |
1 |
p. S130-S131
|
artikel
|
| 312 |
P220 - The NOD2 variants rs2066843 and rs2076756 are novel independent Crohn's disease susceptibility gene variants associated with severe penetrating disease phenotype resulting in frequent need for surgery
|
Seiderer, J.
|
|
|
3 |
1 |
p. S97
|
artikel
|
| 313 |
P281 - The prevalence of antibodies against cyclic citrullinated peptide (anti-CCP) is low in patients with inflammatory bowel disease with or without arthritis
|
Papamichael, K.
|
|
|
3 |
1 |
p. S121
|
artikel
|
| 314 |
P028 - The role of hepcidin in Crohn's disease associated anemia
|
Bourikas, L.A.
|
|
|
3 |
1 |
p. S22
|
artikel
|
| 315 |
P060 - The role of MR enterography for detection of enteral fistulas in Crohn's disease correlation with radiological and surgical findings
|
Mankowska-Wierzbicka, D.
|
|
|
3 |
1 |
p. S34
|
artikel
|
| 316 |
P253 - The role of pregnane X receptor (PXR/NR1I2) gene variants in inflammatory bowel disease
|
Seiderer, J.
|
|
|
3 |
1 |
p. S111
|
artikel
|
| 317 |
P070 - The role of preoperative optimalisation before surgery in IBD patients
|
Vasas, P.
|
|
|
3 |
1 |
p. S38-S39
|
artikel
|
| 318 |
P146 - The short-term efficacy and safety of adalimumab in Crohn's disease (CD) patients – a retrospective study
|
Dotan, I.
|
|
|
3 |
1 |
p. S68-S69
|
artikel
|
| 319 |
P299 - The stress mediators adenosine and hydrocortisone impair epithelial wound healing in vitro
|
Goodhand, J.
|
|
|
3 |
1 |
p. S128
|
artikel
|
| 320 |
P153 - The treatment of patients with antibiotic resistant pouchitis using stool coliform sensitivity testing
|
McLaughlin, S.D.
|
|
|
3 |
1 |
p. S71-S72
|
artikel
|
| 321 |
P027 - The usefulness of fecal calprotectin in distinguishing between non-active inflammatory bowel diseases and functional bowel disorders
|
Kosiara, M.
|
|
|
3 |
1 |
p. S21-S22
|
artikel
|
| 322 |
P049 - The value of capsule endoscopy for the phenotypic classification and the management of patients with Crohn's disease
|
Gologan Sr., S.
|
|
|
3 |
1 |
p. S30
|
artikel
|
| 323 |
P076 - Time trends in forty years of diagnostic procedures in inflammatory bowel disease (IBD), in a secondary care teaching hospital
|
Horjus, C.S.
|
|
|
3 |
1 |
p. S40-S41
|
artikel
|
| 324 |
P316 - TNF-α production and differential release of Th1/Th2 cytokines detected in colonic tissues of inflammatory bowel disease patients but not controls
|
Ng, S.C.
|
|
|
3 |
1 |
p. S134-S135
|
artikel
|
| 325 |
P286 - Tocotrienols have an anti-fibrogenic effect by inducing human intestinal fibroblast apoptosis and autophagy
|
Luna, J.
|
|
|
3 |
1 |
p. S123
|
artikel
|
| 326 |
P150 - Tolerability and safety of accelerated infliximab infusions: a prospective referral center registry and patient survey
|
Van Assche, G.
|
|
|
3 |
1 |
p. S70-S71
|
artikel
|
| 327 |
P091 - Tolerance and efficacy of a late retreatment with infliximab in Crohn's disease
|
Laharie, D.
|
|
|
3 |
1 |
p. S47
|
artikel
|
| 328 |
P134 - Transcolonic specimen removal in laparoscopic ileocolic resection for Crohn's disease: initial experience
|
Eshuis, E.J.
|
|
|
3 |
1 |
p. S64
|
artikel
|
| 329 |
P017 - Transrectal endoscopic ultrasound (TRUS) elastography in inflammatory bowel disease (IBD)
|
Rustemovic, N.
|
|
|
3 |
1 |
p. S18
|
artikel
|
| 330 |
P167 - Treatment with anti-tumor necrosis factor alpha antibodies and sub-obstructive symptoms in Crohn's disease: a prospective longitudinal study
|
Condino, G.
|
|
|
3 |
1 |
p. S77
|
artikel
|
| 331 |
P301 - Tumor necrosis factor-alpha gene polymorphism in Russian patients with ulcerative colitis
|
Kharitonov, A.G.
|
|
|
3 |
1 |
p. S129
|
artikel
|
| 332 |
P159 - Ulcerative colitis might prevent colonic diverticulosis
|
Yönal, O.
|
|
|
3 |
1 |
p. S73-S74
|
artikel
|
| 333 |
P079 - Ultrasonography and perianal involvement in inflammatory bowel disease
|
Moreira, T.
|
|
|
3 |
1 |
p. S42
|
artikel
|
| 334 |
P030 - Ultrasound assessment of the degree of transmural lesions predicts the severity of endoscopic lesions of the ileo-colonic anastomosis after “curative” ileal resection in Crohn's disease
|
Pallotta, N.
|
|
|
3 |
1 |
p. S22-S23
|
artikel
|
| 335 |
P057 - Usefulness of the Quantiferon TB Gold Test in assessing the necessity for TB prophylaxis in IBD patients treated with biologicals
|
Bortlik, M.
|
|
|
3 |
1 |
p. S33
|
artikel
|
| 336 |
P080 - Use of abdominal ultrasonography in detection of possible asymptomatic thrombosis in patients with inflammatory bowel disease including evaluation of inherited and acquired prothrombotic factors
|
Tozzi, I.
|
|
|
3 |
1 |
p. S42
|
artikel
|
| 337 |
P139 - Vitamin B12 deficiency in Crohn's disease: oral supplementation is effective
|
Gomollón, F.
|
|
|
3 |
1 |
p. S66
|
artikel
|
| 338 |
P097 - What factors influence adhesion to therapy in inflammatory bowel disease?
|
Bermejo, F.
|
|
|
3 |
1 |
p. S49
|
artikel
|
| 339 |
P086 - Which activity index for ulcerative colitis (UC)? Evaluation of inter-observer variation in clinical, endoscopic and composite indices
|
Walsh, A.J.
|
|
|
3 |
1 |
p. S45
|
artikel
|
| 340 |
P206 - Which patient population profits best from a high dose, once daily treatment with 3.0g mesalazine for maintaining clinical remission in ulcerative colitis? A subgroup analysis of a double-blind, double-dummy, randomised, controlled, dose-ranging study
|
Kruis, W.
|
|
|
3 |
1 |
p. S92
|
artikel
|
| 341 |
P010 - Wireless capsule endoscopy and small intestine contrast ultrasonography (SICUS) in the diagnostic assessment of small bowel in pediatric patients with Crohn's disease
|
Pallotta, N.
|
|
|
3 |
1 |
p. S15
|
artikel
|
| 342 |
P042 - 2 year follow up of adalimumab therapy in patients with Crohn's disease
|
Kemp, K.
|
|
|
3 |
1 |
p. S27-S28
|
artikel
|
| 343 |
P246 - Young patients with Crohn's disease are at increased risk for psychiatric disorders
|
Loftus Jr., E.V.
|
|
|
3 |
1 |
p. S108
|
artikel
|
| 344 |
Reduction of dietary poorly absorbed short-chain carbohydrates (FODMAPs) improves abdominal symptoms in patients with inflammatory bowel disease—a pilot study
|
Gearry, Richard B.
|
|
|
3 |
1 |
p. 8-14
|
artikel
|
| 345 |
Reply to Dr. Caprilli et al.'s letter
|
Ferrante, Marc
|
|
|
3 |
1 |
p. 45
|
artikel
|
| 346 |
Table of Contents
|
|
|
|
3 |
1 |
p. v
|
artikel
|
| 347 |
Talking about life and IBD: A paradigm for improving patient–physician communication
|
Mitchell, Rod
|
|
|
3 |
1 |
p. 1-3
|
artikel
|
| 348 |
2 - Targeting gut T cell Ca2+ release-activated Ca2+ channels inhibits Th1 cytokine production and T-box transcription factor T-bet in inflammatory bowel disease
|
Di Sabatino, A.
|
|
|
3 |
1 |
p. S3
|
artikel
|
| 349 |
6 - Temporal stability of faecal microbiota by Inter Spacer rDNA bacterial profiling (IS-pro)
|
Grasman, M.E.
|
|
|
3 |
1 |
p. S5
|
artikel
|
| 350 |
4 - The lymphatic system controls intestinal inflammation and inflammation-associated colon cancer through the chemokine decoy receptor D6
|
Vetrano, S.
|
|
|
3 |
1 |
p. S4
|
artikel
|
| 351 |
7 - Thiopurine therapy is associated with a three-fold decrease in the incidence of advanced colorectal neoplasia in IBD patients with longstanding extensive colitis: the CESAME prospective data
|
Beaugerie, L.
|
|
|
3 |
1 |
p. S5-S6
|
artikel
|
| 352 |
13 - WELCOME: A randomized, double-blind, controlled trial comparing certolizumab pegol 400mg every 2 weeks with every 4 weeks for maintenance of response and remission in patients with moderate-to-severe Crohn's disease with secondary failure to infliximab
|
Sandborn, W.J.
|
|
|
3 |
1 |
p. S8-S9
|
artikel
|
Tijdschrift beschrijving